Replies to post #417508 on Amarin Corp Plc (AMRN)

[jfmcrr]

A positive Brave study would not only validate Vascepa as a treatment for Altzheimers...but it would also validate the concept that Vascepa's effectiveness is due to its anti-inflammatory qualities....This would further made the case for its use in other inflammatory diseases such as CVD etc.

Add Parkinsons/Lewy Body Dementia/et al. Subtract "Just buy 'fish oil.'"

Who's got a best guess for when BRAVE drops?